Positron Corporation
POSC • Medical - Devices
$1.80
▼ -0.01 (-0.77%)
Current price
EarningsLatest report: Mar 31, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$58.97M
Growth
-33.5%
Cash Flow
0/5
Trend
Negative
Evidence
Healthy liquidity · 1.39Negative growth trendWeak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 15, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.80
Change-0.77%
Shares Out32.83M
Market Cap$58.97M
Enterprise Value$59.03M
52W Range1.25 - 2.74
Beta0.11
P/E-5.65
P/S112.73
P/B367.28
P/FCF-12.54
EV/Sales112.84
Price$1.80
Change-0.77%
Shares Out32.83M
Market Cap$58.97M
Enterprise Value$59.03M
52W Range1.25 - 2.74
Beta0.11
P/E-5.65
P/S112.73
P/B367.28
P/FCF-12.54
EV/Sales112.84
EV/EBITDA-5.73
EV/FCF-12.56
Earnings Yield-17.71%
FCF Yield-7.97%
Dividend Yield0.00%
Gross Margin-4.58%
Oper. Margin-22.75%
Profit Margin-22.98%
Debt/Eq1.35
Current Ratio1.39
Quick Ratio1.11
Revenue 5Y-33.50%
Volume4.00K
Avg Volume40.83K
Investment DNA
How strong this company looks for long-term investors
26
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
55/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Healthy liquidity · 1.39Negative growth trendWeak profitability
Analyst view
No analyst data available now.
🧾
No insider activity
No recent insider transactions available.